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Abstract
Background: The major histocompatibility complex (MHC) molecule plays a central role in
controlling the adaptive immune response to infections. MHC class I molecules present peptides
derived from intracellular proteins to cytotoxic T cells, whereas MHC class II molecules stimulate
cellular and humoral immunity through presentation of extracellularly derived peptides to helper
T cells. Identification of which peptides will bind a given MHC molecule is thus of great importance
for the understanding of host-pathogen interactions, and large efforts have been placed in
developing algorithms capable of predicting this binding event.
Results: Here, we present a novel artificial neural network-based method, NN-align that allows for
simultaneous identification of the MHC class II binding core and binding affinity. NN-align is trained
using a novel training algorithm that allows for correction of bias in the training data due to
redundant binding core representation. Incorporation of information about the residues flanking
the peptide-binding core is shown to significantly improve the prediction accuracy. The method is
evaluated on a large-scale benchmark consisting of six independent data sets covering 14 human
MHC class II alleles, and is demonstrated to outperform other state-of-the-art MHC class II
prediction methods.
Conclusion: The NN-align method is competitive with the state-of-the-art MHC class II peptide
binding prediction algorithms. The method is publicly available at http://www.cbs.dtu.dk/services/
NetMHCII-2.0.
Background
Major histocompatibility complex (MHC) molecules play
an essential role in host-pathogen interactions determin-
ing the onset and outcome of many host immune
responses. Only a small fraction of the possible peptides
that can be generated from proteins of pathogenic organ-
isms actually generate an immune response. MHC class II
molecules present peptides derived from proteins taken
up from the extracellular environment. They stimulate cel-
lular and humoral immunity against pathogenic microor-
ganisms through the actions of helper T lymphocytes. In
order for a peptide to stimulate a helper T lymphocyte
response, it must bind MHC II in the endocytic organelles
[1].
The MHC class I molecule is highly specific and binds a
limited set of peptides of a narrow length distribution [2].
In contrast to this, the MHC class II molecule is highly
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promiscuous both with respect to composition and length
of the peptide ligands [3,4]. During the last decade, large
efforts have been invested in developing methods to allow
for in silico screening of pathogenic organisms with the
purpose of identifying peptides that will bind MHC class
II molecules in a given host [5-20]. The majority of these
methods are trained on limited data sets covering a single
or a few MHC molecules. The binding of a peptide to a
given MHC molecule is predominantly determined by the
amino acids present in the peptide-binding core. How-
ever, peptide residues flanking the binding core (so-called
peptide flanking residues, PFR) do also to some degree
affect the binding affinity of a peptide [21,22]. Most pub-
lished methods for MHC class II binding prediction how-
ever focus on identifying the peptide-binding core only,
ignoring the effects on the binding affinity of PFRs.
In two recent publications, we have demonstrated i) how
a stabilization matrix method (SMM-align) could be
applied to simultaneously identify the peptide-binding
core and predict the binding strength [20], and ii) how
this peptide core alignment together with information
about the peptide flanking residues could be integrated in
a neural network-based algorithm that allows for pan-spe-
cific HLA-DR binding prediction (NetMHCIIpan) [23].
Both the SMM-align and the NetMHCIIpan methods have
in recent benchmarks been shown to be among the best
publicly available methods for HLA-DR peptide binding
prediction [18,24].
Here, we show how an artificial neural network-based
alignment method, NN-align, can significantly outper-
form both the SMM-align  and  NetMHCIIpan  methods.
The NN-align method includes explicit encoding of the
peptide flanking residues in terms of amino acid compo-
sition and length, as well as a novel scheme for neural net-
work training that deals with the data redundancy
inherent in the peptide data due to multiple examples of
identical binding cores. The NN-align method is trained
on a large data set of more than 14,000 quantitative pep-
tide MHC binding values covering 14 HLA-DR alleles. The
performance is evaluated on five independent data sets
and its performance is compared to the best publicly
available state-of-the-art MHC class II prediction meth-
ods.
Methods
Data
A quantitative IEDB HLA-DR restricted peptide-binding
data set was obtained from the data published by Nielsen
et al. [23]. The data set comprises 14 HLA-DR alleles each
characterized by at least 420 and up to 5166 peptide bind-
ing data points. To minimize the peptide overlap between
training and testing data, the binding data for each HLA-
DR allele was partitioned into 5 data sets using the
approach outlined by Nielsen et al. [20] minimizing the
sequence overlap between the training and test data. Each
data set and corresponding partition is made available
online at http://www.cbs.dtu.dk/suppl/immunology/
NetMHCII-2.0.php.
The method was evaluated further on five independent
data sets taken from recent MHC class II benchmark pub-
lications. The HLA-DR class II ligand data set from the
SYFPEITHI database [4] was taken from Nielsen et al. [23].
Only ligands restricted by one of the 14 HLA-DR alleles in
the quantitative binding data set were included. This SYF-
PEITHI data set consists of 475 MHC ligands. The peptide
core data set was also taken from Nielsen et al. [23] to
evaluate the ability of the proposed method to identify the
core of HLA-DR binding peptides. As a further evaluation,
the method was evaluated against the benchmark data
sets published by Lin et al. [24] and Wang et al. [18]. The
Lin data set data set contains binding affinities of 103
overlapping peptides to seven common HLA-DR mole-
cules (DRB1*0101, 0301, 0401, 0701, 1101, 1301, and
1501). Only six of the seven alleles were included since
the DRB1*1301 allele is not covered by the data in the
quantitative training data set. All methods from the Lin
benchmark that cover all six alleles and which were
labeled as "best performing" by Lin at al. were included in
the benchmark. The Wang et al. benchmark consists of
quantitative binding data to 14 HLA-DR alleles. In this
benchmark, the predictive performance of the NN-based
method was evaluated using 10-fold cross-validation.
Finally, to investigate how the performance of the NN-
based method depends on the inherent similarity in the
peptide data, the method was benchmarked using the El-
Manzalawy benchmark data set [25]. Three data sets with
different degrees of inherent peptide similarity were
selected from the IEDB benchmark data set: UPDS;
unique peptides from the IEDB data base, SRDS1;
sequence similarity reduced UPDS data excluding pep-
tides sharing 9 mer subsequences, and SRDS2; sequence
similarity reduced SRDS1 data ensuring maximum 80%
similarity between pairs of peptides. Three support vector
machine (SVM) based MHC class II binding prediction
methods were included in the El-Manzalawy et al. bench-
mark; composition transition distribution (CTD), local
alignment kernel (LA), and k-spectrum kernel (5-spec-
trum). The performance of the different methods was
evaluated using the AUC measure since this is the only
measure provided in the El-Manzalawy paper that does
not depend on binding affinity classification.
Method
NN-align  was implemented as a conventional feed-for-
ward artificial neural network method [26]. The method
consists of a two-step procedure that simultaneously esti-
mates the optimal peptide binding register (core) and net-BMC Bioinformatics 2009, 10:296 http://www.biomedcentral.com/1471-2105/10/296
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work weight configuration. Initially, all network weights
were assigned random values. Given this set of network
weights, the core of a given peptide was identified as the
highest scoring of all 9 mers contained within the peptide.
The score of a 9 mer peptide was calculated using the con-
ventional feed-forward algorithm. The network weights
were updated using gradient descent back-propagation.
Given a peptide core alignment, the weights were updated
to lower the sum of squared errors between the predicted
binding score and the measured binding affinity target
value. The quantitative binding data contains a large
degree of redundancy since many peptide data points
have been measured repeatedly with single amino acid
mutations in order to identify for instance the effect of the
amino acids flanking the peptide-binding core. To limit
the effect of such data redundancy, the network back-
propagation was modified so that the step-size of back-
propagation was divided by the binding core redundancy
of the given peptide. The binding core redundancy was
calculated using a Hobohm-1 algorithm [27] to define
clusters of identical binding cores. For a peptide belong-
ing to a cluster containing five peptides with identical
binding core, the step-size of back-propagation was thus
divided by five. The identification of peptide clusters was
done repeatedly during the network training based on the
given binding core configuration.
The 9 mer peptide was encoded to the network as
described for the NetMHCIIpan by Nielsen et al. [23]. In
brief, the peptide core was presented to the network using
Blosum encoding, where each amino acid was encoded by
the BLOSUM log-odds vector [28,29]. The peptide flank-
ing regions (PFR) were presented as the average BLOSUM
substitution frequency vector over a maximum length of
three amino acids. The PFR length was encoded as LPFR/3,
1-LPFR/3, where LPFR is the length of the PFR (between 0
and 3), and the peptide length was encode as LPEP, 1-LPEP,
where LPEP = 1/(1+exp((L-15)/2)) and L is the peptide
length. To impose an amino acid preference at the P1
position of the binding core, a log-odds position specific
scoring matrix (PSSM) was constructed using the Gibbs
sampler method for class II binding prediction [10] using
the peptide binders in the training data for the allele in
question. Next, the core P1 amino acid was encoded as the
P1-PSSM score for that given amino acid, i.e. for a given
peptide binding register, one additional value was added
to the network input as the score of the core P1 amino
acid at the P1 position in the PSSM. For each peptide core,
the input to the neural network thus consisted of the pep-
tide sequence (9×20 = 180 inputs), the PFRs (2×20 = 40
inputs), the peptide length (2 inputs), the length of the C
and N terminal PFR's (2×2 = 4 inputs), and the P1-PSSM
score (1 input) resulting in a total of 227 input values. The
peptide binding affinity IC50 values were encoded to the
neural network as log-transformed values, using the rela-
tion 1-log (aff)/log(50000), where aff is the measured
binding affinity (IC50) in nM units [29].
The networks were trained using cross-validation. Net-
work ensembles were trained with 2, 10, 20, 40 and 60
hidden neurons, respectively. The procedure of i) identify-
ing the optimal peptide core, and of ii) updating the net-
work weights to lower the predictive error was repeated
for 500 cycles for each network architecture. Since the
"search landscape" has a large set of local minima, each
with close to identical performance values, the network
training was run 10 times, each time with different initial
configuration values, for each network architecture. This
led to a significantly improved prediction accuracy (data
not shown). In total 50 (5 architectures*10 seeds) net-
works were created for each training/test set configura-
tion. For each training/test set configuration, the 10
networks with the highest test-set Pearson correlation
coefficient were selected to form the final network ensem-
ble. The binding core of a given peptide was assigned by a
majority vote of the networks in the ensemble.
Statistical tests
All statistical comparisons were made using one-tailed
binomial tests. For each comparison, it is calculated how
often one method outperforms the other (excluding ties),
and based on these numbers one-tailed p-values were cal-
culated. P-values less than 0.05 were taken to be signifi-
cant.
SMM-align and NetMHCIIpan methods
The  SMM-align  method was trained as described by
Nielsen et al. [20] on the IEDB quantitative data set com-
bined with HLA-DR ligand data obtained from the SYF-
PEITHI database [30]. The NetMHCIIpan  method was
used via the online server-link http://www.cbs.dtu.dk/
services/NetMHCIIpan.
Results
The quantitative IEDB benchmark data set
The predictive performance of the artificial neural net-
work (NN) based methods on the quantitative IEDB
benchmark data set is shown in Table 1. The performance
was estimated using five-fold cross-validation. In each
cross-validation, 1/5 of the data were left out for evalua-
tion and the remaining 4/5 were used for a four-fold cross-
validated training as described in the methods section.
The four-fold cross-validated training resulted in an
ensemble of 40 networks. The predictive binding affinity
for the peptides in the evaluation set was next calculated
as a simple average over the 40 network predictions, and
the peptide-binding core was identified by a majority
vote. In this approach, no peptide from the evaluation set
was included in either the network training or the identi-
fication of the optimal network ensemble.BMC Bioinformatics 2009, 10:296 http://www.biomedcentral.com/1471-2105/10/296
Page 4 of 10
(page number not for citation purposes)
Table 1 shows the predictive performance in terms of AUC
[31] (area under the receiver operator curve) of the differ-
ent NN-based methods. Performance values in terms of
the Pearson's correlation coefficient are shown in supple-
mentary material [see Additional file 1]. Further, the pre-
dictive performance of the SMM-align [20] and TEPITOPE
[17] methods is given. The TEPITOPE method does not
produce prediction values that are linearly related to the
log-transformed binding affinities, which is why for this
method only AUC values are reported. The performance is
shown for five different versions of the NN-based method,
each including different degrees of sophistication in the
training algorithm. NN is the standard NN-based method,
NN-W  is the NN-based method including data redun-
dancy step-size rescaling, NN-P1 is the NN-based method
including PSSM-P1 amino acid encoding, NN-W-P1 is the
NN-based method including both data redundancy step-
size rescaling and PSSM-P1 amino acid encoding, and
NN-xPFR  is the NN-W-P1  method excluding peptide-
flanking residue encoding.
From Table 1, it is clear that the NN-based methods that
include data redundancy step-size rescaling (NN-W and
NN-W-P1) significantly outperformed (p < 0.05) their
non-rescaled counterparts (NN and NN-P1). When com-
pared to the SMM-align and TEPITOPE methods, the NN-
based methods all showed a significantly improved pre-
dictive performance (p < 0.05, in all cases). Only for two
alleles (DRB1*0405 and DRB1*0901) did the SMM-align
method outperform NN-based methods, while TEPITOPE
did not perform best for any of the alleles.
The per-allele binomial statistical test applied here places
equal weight on all alleles and does not take into account
the large differences in the peptide data available for each
allele. To place a relative weight on the performance of the
different alleles, Table 1 includes a performance value for
each method calculated as the mean weighted by the
number of peptides per allele. However, a pooled statisti-
cal test on all peptide data would favor methods being
able to accurately predict binding for the alleles described
by most data over other methods. In the per-allele bino-
mial test for instance, the methods NN and NN-P1 have
comparable performance. NN has the best performance
for 7 alleles and the NN-P1 method performs best for 5
(see Table 1). This difference is not significant. When per-
forming a binomial test on the predicted error per peptide
for the pooled set of 14,607 peptides, the difference
between the two methods comes out highly significant in
favor of the NN method (p < 0.007). However, 35% of the
peptide binding data are measured for the DRB1*0101
allele. The NN method performs best of the four NN-
based methods on the HLA-DRB1*0101 allele and pool-
ing the data hence favors this method over the other.
When performing the same test on the pooled peptide
data excluding the DRB1*0101 data, the two methods
Table 1: Predictive performance for the 14 HLA-DR alleles in the quantitative IEDB benchmark dataset.
Allele # TEPITOPE SMM-align NN NN-W NN-P1 NN-W-P1 NN-xPFR
DRB1*0101 5166 0.720 0.802 0.837 0.836 0.833 0.833 0.813
DRB1*0301 1020 0.664 0.795 0.808 0.816 0.817 0.817 0.778
DRB1*0401 1024 0.716 0.751 0.768 0.771 0.764 0.766 0.764
DRB1*0404 663 0.770 0.801 0.815 0.818 0.816 0.817 0.814
DRB1*0405 630 0.759 0.789 0.771 0.781 0.779 0.784 0.773
DRB1*0701 853 0.761 0.812 0.844 0.841 0.839 0.838 0.813
DRB1*0802 420 0.766 0.787 0.826 0.832 0.820 0.822 0.802
DRB1*0901 530 0.655 0.623 0.616 0.618 0.640 0.623
DRB1*1101 950 0.721 0.796 0.822 0.823 0.818 0.813 0.802
DRB1*1302 498 0.652 0.785 0.822 0.831 0.822 0.824 0.811
DRB1*1501 934 0.686 0.727 0.754 0.758 0.754 0.754 0.761
DRB3*0101 549 0.836 0.855 0.844 0.838 0.841 0.831
DRB4*0101 446 0.793 0.811 0.811 0.815 0.818 0.813
DRB5*0101 924 0.680 0.761 0.789 0.797 0.790 0.790 0.787
Ave 0.718 0.778 0.796 0.798 0.795 0.797 0.785
Ave* 0.716 0.785 0.809 0.810 0.807 0.808 0.793
The performance was estimated using five-fold cross-validation and is given as the area under the ROC curve (AUC) calculated using a binding 
affinity threshold of 500 nM. SMM-align is the SMM-align method described by Nielsen et al. [20] re-trained on the quantitative benchmark data set. 
TEPITOPE refers to the method developed by Sturniolo et al. [17]. NN is the standard NN-based method, NN-W is the NN-based method including 
data redundancy step-size rescaling, NN-P1 is the NN-based method including PSSM-P1 amino acid encoding, NN-W-P1 is the NN-based method 
including data redundancy step-size rescaling and PSSM-P1 amino acid encoding. NN-xPFR is the NN-W-P1 method excluding peptide-flanking residue 
encoding. For each allele, the best performing NN method is highlighted in bold and the best performing of all methods is underlined. Ave is the 
average per-allele performance over all 14 alleles, and Ave* is the average predictive performance over the 14 alleles weighted by the number of 
data points for each allele.BMC Bioinformatics 2009, 10:296 http://www.biomedcentral.com/1471-2105/10/296
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come out with comparable performance (p < 0.20). Since
it is essential to demonstrate that a prediction method has
high predictive performance across a large set of different
alleles, we therefore here limit the statistical tests to per-
allele binomial tests.
Comparing the performance of the NN-based method
with (NN-W-P1) and without peptide-flanking residue
encoding (NN-xPFR) demonstrated the importance of the
latter for improved prediction accuracy. For 13 of the 14
alleles, did the inclusion of PFR improve the prediction
accuracy (p < 0.005). The direct and linear relationship
between the NN-W-P1 prediction score and the measured
binding affinity is apparent when calculating a least
square linear fit between the prediction score and the log-
transformed binding affinities. Here, the average slope
was 0.86 ± 0.10 and the intercept 0.05 ± 0.05 (data not
shown).
The NN-based method with P1-PSSM amino acid encod-
ing (NN-W-P1) showed a lower performance compared to
the method without P1-PSSM amino acid encoding (NN-
W). However, when investigating the amino acid distribu-
tion at the P1 position of the predicted binding cores of
the two methods, it became apparent that the NN-W-P1
method produces a P1 binding core amino acid prefer-
ence that is in stronger accordance with prior experimen-
tal knowledge than the NN-W  method. Only
hydrophobic amino acids have experimentally been
found to be allowed at the P1 position in the binding core
of HLA-DR molecules [17,32]. For the 14 alleles in Table
1, we found that the NN-W method on average assigned
30% of the predicted binders to have non-conventional
P1 amino acids, whereas the corresponding value for the
NN-W-P1 method was 16%.
Identification of the peptide-binding core
To further investigate the effect of this difference in P1
binding core amino acid preference, the ability to cor-
rectly identify the binding core of HLA-DR binding pep-
tides was investigated. The HLA-DR binding core data set
was taken from Nielsen et al. [23] and consists of 15 pep-
tides where the binding register to a HLA-DR allele has
been determined from the structure of the protein com-
plex. The result of the benchmark is shown in Table 2.
From this table, it is clear that the NN-W-P1 method was
to a higher degree capable of identifying peptide-binding
cores than NN-W. TEPITOPE correctly identified all 15
binding cores, the NN-W-P1  method (together with
SMM-align and NetMHCIIpan) misaligned one peptide by
a single amino acid residue, whereas the NN-W method
misaligned 5 peptides.
Identifying endogenously presented peptides
We next turned to the benchmark of HLA-DR endog-
enously presented ligands. The benchmark was performed
as described by Nielsen et al [23]. In short, the ligand
source protein was split into overlapping peptide
sequences of the length of the ligand. All peptides except
the annotated HLA ligand were taken as negatives. This is
a very strong assumption since suboptimal peptides that
could be presented on the HLA molecule are counted as
Table 2: Identification of peptide binding cores.
Allele Peptide Core TEPITOPE SMM-align NetMHCIIPan NN-W-P1 NN-W
DRB1*0101 AGFKGEQGPKGEPG FKGEQGPKG FKGEQGPKG FKGEQGPKG FKGEQGPKG FKGEQGPKG FKGEQGPKG
DRB1*0101 GELIGILNAAKVPAD IGILNAAKV IGILNAAKV IGILNAAKV IGILNAAKV IGILNAAKV IGILNAAKV
DRB1*0101 PEVIPMFSALSEGATP VIPMFSALS VIPMFSALS VIPMFSALS VIPMFSALS VIPMFSALS VIPMFSALS
DRB1*0101 PKYVKQNTLKLAT YVKQNTLKL YVKQNTLKL YVKQNTLKL YVKQNTLKL YVKQNTLKL YVKQNTLKL
DRB1*0101 VGSDWRFLRGYHQYA WRFLRGYHQ WRFLRGYHQ WRFLRGYHQ WRFLRGYHQ WRFLRGYHQ WRFLRGYHQ
DRB1*0101 AFVKQNAAALA FVKQNAAAL FVKQNAAAL VKQNAAALA FVKQNAAAL FVKQNAAAL FVKQNAAAL
DRB1*0101 AAYSDQATPLLLSPR YSDQATPLL YSDQATPLL YSDQATPLL YSDQATPLL YSDQATPLL YSDQATPLL
DRB1*0301 PVSKMRMATPLLMQA MRMATPLLM MRMATPLLM MRMATPLLM MRMATPLLM MRMATPLLM VSKMRMATP
DRB1*0401 AYMRADAAAGGA MRADAAAGG MRADAAAGG MRADAAAGG YMRADAAAG YMRADAAAG AYMRADAAA
DRB1*0401 PKYVKQNTLKLAT YVKQNTLKL YVKQNTLKL YVKQNTLKL YVKQNTLKL YVKQNTLKL KYVKQNTLK
DRB1*1501 ENPVVHFFKNIVTPR VHFFKNIVT VHFFKNIVT VHFFKNIVT VHFFKNIVT VHFFKNIVT VVHFFKNIV
DRB1*1501 ENPVVHFFKNIVTPRGGSGGGGG VHFFKNIVT VHFFKNIVT VHFFKNIVT VHFFKNIVT VHFFKNIVT VVHFFKNIV
DRB5*0101 GGVYHFVKKHVHES YHFVKKHVH YHFVKKHVH YHFVKKHVH YHFVKKHVH YHFVKKHVH YHFVKKHVH
DRB5*0101 NPVVHFFKNIVTPRTPPPSQ FKNIVTPRT FKNIVTPRT FKNIVTPRT FKNIVTPRT FKNIVTPRT FKNIVTPRT
DRB5*0101 VHFFKNIVTPRTPGG FKNIVTPRT FKNIVTPRT FKNIVTPRT FKNIVTPRT FKNIVTPRT FKNIVTPRT
Correct 15/15 14/15 14/15 14/15 10/15
15 HLA-DR restricted peptides compiled from the protein database [32]. The columns in the table state the HLA restriction, the peptide sequence, 
the binding core as determined from the protein structure, followed by the binding core as predicted by TEPITOPE, SMM-align, NetMHCIIpan, NN-
W-P1 (the NN-based method including data redundancy step-size rescaling and P1-PSSM encoding), and NN-W (the NN-based method including 
data redundancy step-size rescaling), respectively. Erroneous predictions are underlined.BMC Bioinformatics 2009, 10:296 http://www.biomedcentral.com/1471-2105/10/296
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negatives. This setup thus most likely underestimated the
predictive performance, but the effect should be equal for
all methods. For each protein-HLA ligand pair, the predic-
tive performance was estimated as the AUC value. In the
benchmark, we compared the predictive performance of
the NN-based method including data redundancy step-
size rescaling with (NN-W-P1) and without (NN-W)
PSSM-P1 amino acid encoding to that of TEPITOPE and
NetMHCIIpan  [23]. The SMM-align  method was not
included here since it was trained on both quantitative
and HLA ligand binding data [20]. The summary of this
benchmark is shown in Table 3.
For the HLA-DR ligand benchmark, the NN-W-P1 method
including P1-PSSM encoding clearly outperforms its
counterpart,  NN-W, not including P1-PSSM encoding.
Only for two alleles did NN-W outperform the NN-W-P1
method making this difference highly statistically signifi-
cant (p < 0.01). Furthermore, the NN-W-P1 method sig-
nificantly outperformed both the NetMHCIIpan (p < 0.05)
and TEPITOPE (p < 0.05) methods. Likewise, it is clear
that the inclusion of peptide-flanking residues signifi-
cantly improved the predictive performance of the NN-W-
P1 method (p < 0.002).
The Wang el al. benchmark data set
The evaluation of the NN-based method on the Wang et
al. benchmark is shown in Table 4. From this benchmark,
it is clear that the NN-W-P1 and NN-W methods have
similar predictive performance and that they significantly
outperformed all other methods in the benchmark (p <
0.01 in all cases). The NN-based methods were outper-
formed only for one allele (DRB1*0801).
The Lin et al. benchmark data set
The predictive performance of the NN-W-P1 and NN-W
methods was next evaluated on the Lin et al. benchmark
data set [24]. The result of this benchmark is shown in
Table 5. All methods from the Lin benchmark that cover
at least six alleles and that were labeled as "best perform-
ing" by Lin at al. were included in the benchmark. Also
from this benchmark, it is apparent that the NN-W-P1 and
NN-W methods have similar predictive performance and
that they outperformed all other methods in the bench-
mark.
The El-Manzalawy benchmark data set
The recent benchmark by El-Manzalawy and co-workers
[25] demonstrated that the predictive performance of a
given prediction method depends strongly on the inher-
ent peptide similarity in the training data and that a
benchmark ranking of peptide binding prediction algo-
rithms could vary as a function of this similarity. To inves-
tigate to what extent the NN-align  method and its
performance were influenced by peptide similarities, we
compared the performance of the NN-W-P1 and NN-W
Table 3: The HLA-DR ligand benchmark.
Allele N NetMHCIIpan TEPITOPE NN-W-P1 NN-W NN-xPFR
DRB1*0101 37 0.873 0.883 0.899 0.882 0.863
DRB1*0301 26 0.882 0.837 0.862 0.906 0.788
DRB1*0401 209 0.865 0.876 0.865 0.843 0.848
DRB1*0404 46 0.817 0.790 0.776 0.772 0.770
DRB1*0405 35 0.848 0.809 0.892 0.866 0.878
DRB1*0701 36 0.687 0.711 0.761 0.754 0.757
DRB1*0802 1 0.982 0.914 0.984 0.979 0.959
DRB1*0901 4 0.865 0.867 0.864 0.878
DRB1*1101 27 0.873 0.863 0.894 0.876 0.881
DRB1*1302 21 0.605 0.761 0.702 0.687 0.681
DRB1*1501 12 0.770 0.729 0.767 0.766 0.776
DRB3*0101 2 0.957 0.680 0.730 0.681
DRB4*0101 4 0.471 0.540 0.492 0.496
DRB5*0101 15 0.840 0.853 0.877 0.819 0.851
Ave 0.810 0.812 0.804 0.794
Ave* 0.830 0.842 0.824 0.824
Ave** 0.822 0.821 0.844 0.834 0.824
The benchmark data set consists of 475 HLA-DR restricted ligands downloaded from the SYFPEITHI database of MHC ligands covering 14 HLA-DR 
alleles. The predictive performance was estimated in terms of the AUC as described in the text. Ave is the average per-allele performance over all 
14 alleles. Ave* is the average predictive performance over all 475 ligand/HLA-DR pairs. Ave** is the average per allele performance over the 11 
alleles covered by the TEPITOPE method. NetMHCIIpan is the HLA-DR pan-specific method described by Nielsen et al. [23]. TEPITOPE refers to the 
method developed by Sturniolo et al [17]. NN-W-P1 is the NN-based method including data redundancy step-size rescaling and PSSM-P1 amino acid 
encoding. NN-W is the NN-based method including data redundancy step-size rescaling. NN-xPFR is the NN-W-P1 method excluding peptide flanking 
residue encoding. For each allele, the best performing NN method is highlighted in bold and the best performing of all methods is underlined.BMC Bioinformatics 2009, 10:296 http://www.biomedcentral.com/1471-2105/10/296
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methods to the MHC class II binding prediction methods
(5-spectrum, LA, and CTD) included in the El-Manzalawy
paper on three data sets, each with a different degree of
inherent sequence similarity. From the results summa-
rized in Table 6 (details are given in supplementary mate-
rial [see Additional file 2]) it is clear that the NN-based
methods significantly outperformed the three other meth-
ods included in the benchmark, independent of the inher-
ent peptide similarity in the training data. Only for one
single comparison, NN-W-P1 versus CTD, the difference
was only marginally significant (p < 0.06). The NN-W
method had the highest predictive performance. The dif-
ference to NN-W-P1 was, however, only significant for the
SRDS2 data set (p < 0.05). This analysis demonstrated that
the NN-based methods are robust and perform well also
in situations where the peptide similarity is low.
The NN-align method
From the large set of benchmark studies, we conclude that
the two methods NN-W-P1 and NN-W share comparable
predictive performance. The NN-W-P1  method was
shown to be more accurate in identifying the peptide core
binding register, whereas the NN-W was more accurate
when predicting the binding affinity. However, none of
Table 4: Predictive performance in terms of the AUC on the Wang benchmark data set.
Allele ARB MHC2Pred MHCpred Propred Rankpep SMM-align SVRMHC SYF Cons NN-W-P1 NN-W
DRB1*0101 0.76 0.67 0.62 0.74 0.70 0.77 0.69 0.71 0.79 0.88 0.87
DRB1*0301 0.66 0.53 0.65 0.67 0.69 0.50 0.72 0.82 0.82
DRB1*0401 0.67 0.52 0.60 0.69 0.63 0.68 0.66 0.65 0.69 0.73 0.72
DRB1*0404 0.72 0.64 0.79 0.66 0.75 0.80 0.83 0.83
DRB1*0405 0.67 0.51 0.75 0.62 0.69 0.62 0.72 0.81 0.80
DRB1*0701 0.69 0.63 0.78 0.58 0.78 0.68 0.83 0.86 0.87
DRB1*0802 0.74 0.70 0.77 0.75 0.82 0.79 0.81
DRB1*0901 0.62 0.48 0.61 0.66 0.73 0.68 0.68 0.69
DRB1*1101 0.73 0.60 0.80 0.70 0.81 0.80 0.89 0.89
DRB1*1302 0.79 0.54 0.58 0.52 0.69 0.73 0.78 0.78
DRB1*1501 0.70 0.63 0.72 0.62 0.74 0.64 0.67 0.72 0.77 0.76
DRB3*0101 0.59 0.68 0.85 0.86
DRB4*0101 0.74 0.61 0.65 0.71 0.74 0.86 0.86
DRB5*0101 0.70 0.59 0.79 0.73 0.75 0.63 0.79 0.87 0.87
Ave 0.70 0.59 0.62 0.73 0.64 0.73 0.65 0.66 0.76 0.82 0.82
NN-W-P1 is the NN-based method including data redundancy step-size rescaling and P1-PSSM encoding and NN-W is the NN-based method 
including data redundancy step-size rescaling. Both methods were evaluated using 10-fold cross-validation. The performance values for the 9 other 
methods were taken from Wang et al. [18]. For each allele, the best performing NN method is highlighted in bold and the best performing of all 
methods is underlined.
Table 5: Predictive performance in terms of the AUC on the Lin benchmark data set.
Method DRB1*0101 DRB1*0301 DRB1*0401 DRB1*0701 DRB1*1101 DRB1*1501 Ave
IEDB_SMM 0.81 0.71 0.79 0.67 0.84 0.67 0.75
IEDB_SAT 0.89 0.69 0.75 0.74 0.83 0.66 0.76
IEDB_Cons 0.83 0.67 0.72 0.80 0.84 0.66 0.75
Multipred_SVM 0.86 0.80 0.65 0.70 0.78 0.62 0.74
NetMHCII 0.77 0.69 0.81 0.62 0.78 0.65 0.72
NetMHCIIpan 0.84 0.65 0.81 0.83 0.81 0.79 0.79
Propred 0.89 0.70 0.75 0.74 0.83 0.66 0.76
SVMHC 0.86 0.69 0.75 0.74 0.83 0.66 0.76
SYF 0.72 0.65 0.69 0.70 0.59 0.77 0.69
NN-W-P1 0.90 0.78 0.84 0.75 0.85 0.79 0.82
NN-W 0.90 0.79 0.80 0.76 0.83 0.82 0.81
NN-W-P1 is the NN-based method including data redundancy step-size rescaling and P1-PSSM encoding and NN-W the NN-based method including 
data redundancy step-size rescaling. All other methods are described in the Lin et al. publication. The AUC was calculated using the following 
binding affinity threshold values for each of the 6 alleles: DRB1*0101, 0401, 0701, and 1501 threshold = 100 nM, DRB1*0301, 1101, and 1301, 
threshold = 1000 nM (Lin HH personal communication). The performance values for the 9 methods above the dotted line were taken from Lin et 
al. [24]. For each allele, the best performing NN method is highlighted in bold and the best performing method is underlined.BMC Bioinformatics 2009, 10:296 http://www.biomedcentral.com/1471-2105/10/296
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these differences were consistently statistically significant.
The final method, called NN-align, was therefore imple-
mented with a switch that allows the user to select
whether or not to include the P1-PSSM amino acid prefer-
ence encoding.
Discussion
Prediction of which peptides will bind to a given MHC
molecule has great implications for the understanding of
how a given host will react to a pathogen infection. Here,
we have developed an artificial neural network-based
method, NN-align, for MHC class II peptide binding pre-
diction. The NN-align method is inspired by the earlier
published Gibbs sampler [10], SMM-align [20], and NetM-
HCIIpan [23] methods. The method is trained on a large
set of quantitative peptide binding data consisting of
more than 14,000 peptide affinity values covering 14
human MHC class II DR molecules. Each peptide is
encoded to the method in terms of the peptide binding
core and information about the length and composition
of the residues flanking this core. NN-align was trained
using a novel training algorithm that allows for correction
of bias in the training data due to redundant binding core
representation. Inclusion of peptide flanking residues was
shown to significantly improve the prediction accuracy.
The method was benchmarked on six independent data
sets and was shown to consistently and significantly out-
perform other state-of-the-art MHC class II prediction
algorithms, like TEPITOPE, SMM-align, and NetMHCII-
pan. In particular, it was demonstrated that the NN-align
method could provide both accurate quantitative predic-
tions that directly translate into IC50 binding values and
correct identification of the peptide-binding core.
In contrast to the SMM-align method (and other matrix-
based methods), NN-align is neural network based and
can hence take into account higher order sequence corre-
lations. For MHC class I binding, this has been demon-
strated to be of importance for accurate prediction of
peptide binding to MHC molecules [29]. Furthermore,
NN-align  incorporates PFR and peptide length directly
into the training of the method. This is in contrast to
SMM-align, where the PFR and peptide length are dealt
with in an ad-hoc manner. The allele-specific NN-align
and pan-specific NetMHCIIpan methods are highly simi-
lar in their design and use of peptide features. The pan-
specific method, however, is one single universal method
capable of predicting binding for all HLA-DR alleles of
known protein sequence, in contrast to the allele-specific
method, NN-align, that is trained individually for each
allele. As observed for MHC class I methods, it is therefore
expected that the allele-specific method will outperform
the pan-specific method for alleles where sufficient data is
available to accurately characterize the binding motif, as is
the case for most alleles in the quantitative data set used
here [33].
The NN-align algorithm, even though here only applied to
the problem of peptide MHC class II binding prediction
based on peptide data points, should be generally appli-
cable to find subtle linear sequence motifs in large scale
quantitative data sets like peptide chip data for MHC
binding, TCR recognition, monoclonal antibodies etc.,
where the precise location of the receptor peptide interac-
tion is not a priori known [34].
Conclusion
We have developed a method, NN-align, for prediction of
peptide binding to MHC class II molecules. NN-align was
trained using a novel training algorithm that allowed for
correction of bias in the training data due to redundant
binding core representation. The predictive performance
of the method was significantly improved by incorpora-
tion of information from residues flanking the peptide-
binding core. Large scale benchmarking comprising six
independent data sets covering 14 human MHC class II
alleles demonstrated that NN-align outperformed other
state-of-the-art MHC class II prediction methods. The
method and benchmark data are made publicly available
at http://www.cbs.dtu.dk/services/NetMHCII-2.0.
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Table 6: Predictive performance in terms of the AUC on the 
IEDB El-Manzalawy benchmark.
UPDS SRDS1 SRDS2
NN-W-P1 0.863 0.699 0.673
NN-W 0.864 0.705 0.676
CTD 0.782 0.639 0.634
LA 0.802 0.645 0.606
5-spectrum 0.748 0.429 0.390
The methods included are NN-W-P1 (the NN-based method including 
data redundancy step-size rescaling and P1-PSSM encoding), NN-W 
(the NN-based method including data redundancy step-size rescaling), 
CTD, LA, and 5-spectrum. The performance values for the latter 
three methods are taken from the El-Manzalawy publication [25]. The 
benchmark data sets are UPDS: Unique peptides from the IEDB 
database, SRDS1: Sequence similarity reduced UPDS data excluding 
peptides sharing 9 mer subsequences, and SRDS2: Sequence similarity 
reduced SRDS1 data ensuring maximum more than 80% similarity 
between pairs of peptides. For each allele, the best performing NN-
based method is highlighted in bold and the best performing method 
is underlined.BMC Bioinformatics 2009, 10:296 http://www.biomedcentral.com/1471-2105/10/296
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